LENALIDOMIDA KERN PHARMA 20 MG CAPSULAS DURAS EFG 西班牙 - 西班牙文 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

lenalidomida kern pharma 20 mg capsulas duras efg

kern pharma s.l. - lenalidomida - cÁpsula dura - 20 mg - lenalidomida 20 mg - lenalidomida

ROSUVASTATINA/EZETIMIBA KERN PHARMA 10 MG/10 MG CAPSULAS DURAS 西班牙 - 西班牙文 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

rosuvastatina/ezetimiba kern pharma 10 mg/10 mg capsulas duras

kern pharma s.l. - rosuvastatina calcica; ezetimiba - cÁpsula dura - 10 mg/10 mg - rosuvastatina calcica 10 mg; ezetimiba 10 mg - rosuvastatina y ezetimiba

ROSUVASTATINA/EZETIMIBA KERN PHARMA 20 MG/10 MG CAPSULAS DURAS 西班牙 - 西班牙文 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

rosuvastatina/ezetimiba kern pharma 20 mg/10 mg capsulas duras

kern pharma s.l. - rosuvastatina calcica; ezetimiba - cÁpsula dura - 20 mg/10 mg - rosuvastatina calcica 20 mg; ezetimiba 10 mg - rosuvastatina y ezetimiba

DEXAMETHASONE KERN PHARMA 以色列 - 英文 - Ministry of Health

dexamethasone kern pharma

mbi pharma ltd., israel - dexamethasone phosphate ( as sodium phosphate ) - solution for injection / infusion - dexamethasone phosphate ( as sodium phosphate ) 4 mg/ml - dexamethasone - dexamethasone kern pharma is indicated in the treatment of:• endocrine diseases such as nonsuppurative thyroiditis, hypercalcaemia associated with cancer and congenital adrenal hyperplasia.• allergy: severe or disabling allergic conditions resistant to conventional treatments, as in: bronchial asthma, contact or atopical dermatitis, seasonal or perennial allergic rhinitis, hypersensitivity reactions to drugs.• ophtalmic: serious inflammatory and allergic processes, acute and chronic, affecting the eyes, such as: iritis and iridocyclitis, chorioretinitis, choroiditis and diffuse posterior uveitis, optical neuritis, allergic conjunctivitis, allergic marginal corneal ulcers.• inflammatory bowel dis.: systemic treatment in exacerbations of ulcerative colitis and regional enteritis.• dermatological diseases (pemphigus, stevens johnson syndrome, exfoliative dermatitis, severe psoriasis and mycosis fungoides) • respiratory diseases (symptomatic sarcoidosis, berylliosis, loeffler's syndrome)• haematological: acquired )autoimmune( haemolytic anaemia, idiopathic thrombocytopenic purpura in adult, pure red cell aplasia• nephrotic syndrome of the idioplathic type or that due to lupus erythematosus• cerebral edema caused by brain tumor, neurosurgery, brain abscess, bacterial meningitis• collagen diseases: active rheumatoid arthritis with severe progressive course, fast destructive remitting forms and / or extra-articular manifestations, juvenile idiopathic arthritis with severe systemic-onset form (still's disease) or locally with no control, rheumatic fever with carditis, dermatomyositis, polymyositis, sle, temporal arteritis.• infectious diseases: bacterial meningitis – adjunct to antibiotics in suspected pneumococcal meningitis and tb meningitis. severe infectious diseases with toxic states (eg tuberculosis, typhoid, brucellosis;. only with simultaneous anti-infective therapy)• fetal lung maturation• chemotherapy – associated nausea and vomiting• multiple myeloma – part of chemotherapy protocols (eg vad)• prevention and treatment of acute mountain sickness/hace

LANSOPRAZOL KERN PHARMA 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG 西班牙 - 西班牙文 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

lansoprazol kern pharma 15 mg capsulas duras gastrorresistentes efg

kern pharma s.l. - lansoprazol - cÁpsula dura gastrorresistente - 15 mg - lansoprazol 15 mg - lansoprazol

LANSOPRAZOL KERN PHARMA 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG 西班牙 - 西班牙文 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

lansoprazol kern pharma 30 mg capsulas duras gastrorresistentes efg

kern pharma s.l. - lansoprazol - cÁpsula dura gastrorresistente - 30 mg - lansoprazol 30 mg - lansoprazol

OLANZAPINA FLAS KERN PHARMA 10 mg COMPRIMIDOS BUCODISPERSABLES EFG 西班牙 - 西班牙文 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

olanzapina flas kern pharma 10 mg comprimidos bucodispersables efg

kern pharma s.l. - olanzapina - comprimido bucodispersable - 10 mg - olanzapina 10 mg - olanzapina

OLANZAPINA FLAS KERN PHARMA 5 mg COMPRIMIDOS BUCODISPERSABLES EFG 西班牙 - 西班牙文 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

olanzapina flas kern pharma 5 mg comprimidos bucodispersables efg

kern pharma s.l. - olanzapina - comprimido bucodispersable - 5 mg - olanzapina 5 mg - olanzapina

DULOXETINA KERN PHARMA 60 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG 西班牙 - 西班牙文 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

duloxetina kern pharma 60 mg cápsulas duras gastrorresistentes efg

kern pharma s.l. - duloxetina hidrocloruro - cÁpsula dura gastrorresistente - 60 mg - duloxetina hidrocloruro 60 mg - duloxetina

DULOXETINA KERN PHARMA 30 MG CÁPSULAS DURAS GASTRORRESISTENTES EFG 西班牙 - 西班牙文 - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

duloxetina kern pharma 30 mg cápsulas duras gastrorresistentes efg

kern pharma s.l. - duloxetina hidrocloruro - cÁpsula dura gastrorresistente - 30 mg - duloxetina hidrocloruro 30 mg - duloxetina